New Israeli Production Site for NurOwn Certified for Quality

New Israeli Production Site for NurOwn Certified for Quality

301098

New Israeli Production Site for NurOwn Certified for Quality

BrainStorm Cell Therapeutics announced that a new cleanroom facility for manufacturing NurOwn, its experimental cell-based therapy for amyotrophic lateral sclerosis (ALS), has received good manufacturing practice (GMP) certification from the Israel Ministry of Health. GMPs are standards set to ensure that batches of a medicine are produced with consistent high quality. This means that the facility — comprising three state-of-the-art cleanrooms leased at the Tel Aviv Sourasky Medical Center’s Institute for Advanced Cellular Therapies — is compliant with…

You must be logged in to read/download the full post.